KOMIPHARM INTERNATIONAL CO., LTD.
Biopharmaceutical company developing products for animal and human health.
041960 | KO
Overview
Corporate Details
- ISIN(s):
- KR7041960006
- LEI:
- Country:
- South Korea
- Address:
- 경기도 시흥시 경제로 17, 시흥시
- Website:
- https://komipharm.co.kr/en/
- Sector:
- Manufacturing
Description
Komipharm International Co., Ltd. is a biopharmaceutical company engaged in the development, manufacturing, and sale of products for both animal and human health. Its Animal Health Division provides a portfolio of veterinary vaccines, pharmaceuticals, and disinfectants. The company's Pharmaceutical Division is dedicated to the research and development of novel therapeutic agents, with key research areas including anticancer drugs and treatments for cancer-related pain and autoimmune diseases. Leveraging extensive experience, the company focuses on intensive R&D to expand its presence in the global bio-industry.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-03-26 00:00 |
주식매수선택권부여에관한신고
|
Korean | 14.9 KB | ||
| 2020-03-26 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 22.8 KB | ||
| 2020-03-26 00:00 |
정기주주총회결과
|
Korean | 21.7 KB | ||
| 2020-03-18 00:00 |
[기재정정]주주총회소집공고
|
Korean | 307.0 KB | ||
| 2020-03-18 00:00 |
[기재정정]의결권대리행사권유참고서류
|
Korean | 264.0 KB | ||
| 2020-03-17 00:00 |
감사보고서제출
|
Korean | 26.8 KB | ||
| 2020-03-17 00:00 |
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 20.9 KB | ||
| 2020-03-17 00:00 |
[기재정정]주주총회소집결의
|
Korean | 16.6 KB | ||
| 2020-03-10 00:00 |
주주총회소집공고
|
Korean | 149.1 KB | ||
| 2020-03-10 00:00 |
의결권대리행사권유참고서류
|
Korean | 105.5 KB | ||
| 2020-03-10 00:00 |
주주총회집중일개최사유신고
|
Korean | 6.2 KB | ||
| 2020-03-06 00:00 |
주주총회소집결의
|
Korean | 8.7 KB | ||
| 2020-02-26 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 12.2 KB | ||
| 2020-02-26 00:00 |
투자판단관련주요경영사항(당사 개발 진행 중인 신약물질 파나픽스(Panaphix)의 국내 식약처 긴급임상시험 신청)
|
Korean | 10.9 KB | ||
| 2020-02-24 00:00 |
투자판단관련주요경영사항(뇌전이 비소세포 폐암환자 대상 PAX-1 치료연구 2상에 대한 대만식약청(TFDA) 임상시험계획승인)
|
Korean | 10.6 KB |
Automate Your Workflow. Get a real-time feed of all KOMIPHARM INTERNATIONAL CO., LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for KOMIPHARM INTERNATIONAL CO., LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for KOMIPHARM INTERNATIONAL CO., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
